SPRB
Spruce Biosciences
SPRB
SPRB
31 hedge funds and large institutions have $44.5M invested in Spruce Biosciences in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20.78% less ownership
Funds ownership: 70.43% → 49.65% (-21%)
32% less capital invested
Capital invested by funds: $65.6M → $44.5M (-$21.1M)
Holders
31
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.72M | |
| 2 | +$690K | |
| 3 | +$439K | |
| 4 |
Goldman Sachs
New York
|
+$380K |
| 5 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$276K |
Top Sellers
| 1 | -$3.99M | |
| 2 | -$2.16M | |
| 3 | -$1.79M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.72M |
| 5 |
SCM
Superstring Capital Management
New York
|
-$1.06M |
